Details of Epigenetic Molecule(EM)
| General Information of EM (ID: EM12146) | |||||||
|---|---|---|---|---|---|---|---|
| Official Symbol |
INTS8
|
||||||
| Official Full Name |
Integrator Complex Subunit 8
|
||||||
| Synonym |
Integrator Complex Subunit 8;C8orf52;Protein Kaonashi-1;INT8;Chromosome 8 Open Reading Frame 52
|
||||||
| Molecule Type |
Protein coding
|
||||||
| Position On Chromosome |
chr8(Start:94813311 - End:94894664)
|
||||||
| Strand |
+
|
||||||
| Uniprot Entry | |||||||
| ENSG ID | |||||||
| Disease Relevance (Click to Show/Hide) | |||||||
| 2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| 8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| Metabolite(s) with this epigenetic modification | |||||||
|---|---|---|---|---|---|---|---|
| Metabolite Name: Docosahexaenoic acid | |||||||
| Detailed Information |
Meta Info
click to show the detail information of this Metabolite
|
[1], [2] | |||||
| Description |
Docosahexaenoic acid could altere the DNA methylation of INTS8 CpG loci.(cg16467757)
|
||||||
| Metabolite Name: Valerate | |||||||
| Detailed Information |
Meta Info
click to show the detail information of this Metabolite
|
[3], [1] | |||||
| Description |
Valerate has been shown to hypermethylate INTS8 CpG site in breast cancer cells.
|
||||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
